Clinical meaning of age-related expression of fecal cytokeratin 19 in colorectal malignancy

Chun Chao Chang, Shung Haur Yang, Chih Cheng Chien, Shu Hung Chen, Shiann Pan, Chia Long Lee, Chih Ming Lin, Hsiao Lun Sun, Chi Cheng Huang, Yih Yiing Wu, Ruey Neng Yang, Chi Jung Huang

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Colorectal cancer (CRC) is one of the leading causes of malignant death worldwide. Because young age of onset is often considered a poor prognostic factor for CRC, it is important to identify the poor outcomes of CRC in a younger population and to consider an aggressive approach by implementing early treatment. Our aim was to specifically quantify the fecal cytokeratin 19 (CK19) transcript from CRC patients and investigate its correlation with clinical stage, tumor malignancy, and age. Methods: The quantitation of fecal CK19 transcript was determined by a quantitative real-time reverse transcription polymerase chain in 129 CRC patients (45 younger than 60 years at diagnosis) and 85 healthy controls. The levels of CK19 protein were examined both in colonic cell lines and tissues. Results: The analysis of 45 younger CRC patients (age ≤ 60 years) revealed that patients at the M1 stage had significantly higher expression levels of fecal CK19 mRNA when compared with healthy controls (p <0.001) and patients at the M0 stage (p = 0.004). Additionally, the degree of consistency between the mean level of fecal CK19 mRNA and the distant metastatic rate in each age interval was up to 89% (p = 0.042). Conclusion: These results indicate that high levels of fecal CK19 mRNA represent a potential marker for colorectal malignancy and for aggressive treatment of younger CRC patients.

Original languageEnglish
Article number1471
Pages (from-to)376
Number of pages1
JournalBMC Cancer
Volume9
DOIs
Publication statusPublished - Oct 22 2009

Fingerprint

Keratin-19
Colorectal Neoplasms
Neoplasms
Messenger RNA
Age of Onset
Reverse Transcription
Cause of Death
Cell Line
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Genetics

Cite this

Clinical meaning of age-related expression of fecal cytokeratin 19 in colorectal malignancy. / Chang, Chun Chao; Yang, Shung Haur; Chien, Chih Cheng; Chen, Shu Hung; Pan, Shiann; Lee, Chia Long; Lin, Chih Ming; Sun, Hsiao Lun; Huang, Chi Cheng; Wu, Yih Yiing; Yang, Ruey Neng; Huang, Chi Jung.

In: BMC Cancer, Vol. 9, 1471, 22.10.2009, p. 376.

Research output: Contribution to journalArticle

Chang, CC, Yang, SH, Chien, CC, Chen, SH, Pan, S, Lee, CL, Lin, CM, Sun, HL, Huang, CC, Wu, YY, Yang, RN & Huang, CJ 2009, 'Clinical meaning of age-related expression of fecal cytokeratin 19 in colorectal malignancy', BMC Cancer, vol. 9, 1471, pp. 376. https://doi.org/10.1186/1471-2407-9-376
Chang, Chun Chao ; Yang, Shung Haur ; Chien, Chih Cheng ; Chen, Shu Hung ; Pan, Shiann ; Lee, Chia Long ; Lin, Chih Ming ; Sun, Hsiao Lun ; Huang, Chi Cheng ; Wu, Yih Yiing ; Yang, Ruey Neng ; Huang, Chi Jung. / Clinical meaning of age-related expression of fecal cytokeratin 19 in colorectal malignancy. In: BMC Cancer. 2009 ; Vol. 9. pp. 376.
@article{503c4f746f5f4f4282942cf344e55887,
title = "Clinical meaning of age-related expression of fecal cytokeratin 19 in colorectal malignancy",
abstract = "Background: Colorectal cancer (CRC) is one of the leading causes of malignant death worldwide. Because young age of onset is often considered a poor prognostic factor for CRC, it is important to identify the poor outcomes of CRC in a younger population and to consider an aggressive approach by implementing early treatment. Our aim was to specifically quantify the fecal cytokeratin 19 (CK19) transcript from CRC patients and investigate its correlation with clinical stage, tumor malignancy, and age. Methods: The quantitation of fecal CK19 transcript was determined by a quantitative real-time reverse transcription polymerase chain in 129 CRC patients (45 younger than 60 years at diagnosis) and 85 healthy controls. The levels of CK19 protein were examined both in colonic cell lines and tissues. Results: The analysis of 45 younger CRC patients (age ≤ 60 years) revealed that patients at the M1 stage had significantly higher expression levels of fecal CK19 mRNA when compared with healthy controls (p <0.001) and patients at the M0 stage (p = 0.004). Additionally, the degree of consistency between the mean level of fecal CK19 mRNA and the distant metastatic rate in each age interval was up to 89{\%} (p = 0.042). Conclusion: These results indicate that high levels of fecal CK19 mRNA represent a potential marker for colorectal malignancy and for aggressive treatment of younger CRC patients.",
author = "Chang, {Chun Chao} and Yang, {Shung Haur} and Chien, {Chih Cheng} and Chen, {Shu Hung} and Shiann Pan and Lee, {Chia Long} and Lin, {Chih Ming} and Sun, {Hsiao Lun} and Huang, {Chi Cheng} and Wu, {Yih Yiing} and Yang, {Ruey Neng} and Huang, {Chi Jung}",
year = "2009",
month = "10",
day = "22",
doi = "10.1186/1471-2407-9-376",
language = "English",
volume = "9",
pages = "376",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Clinical meaning of age-related expression of fecal cytokeratin 19 in colorectal malignancy

AU - Chang, Chun Chao

AU - Yang, Shung Haur

AU - Chien, Chih Cheng

AU - Chen, Shu Hung

AU - Pan, Shiann

AU - Lee, Chia Long

AU - Lin, Chih Ming

AU - Sun, Hsiao Lun

AU - Huang, Chi Cheng

AU - Wu, Yih Yiing

AU - Yang, Ruey Neng

AU - Huang, Chi Jung

PY - 2009/10/22

Y1 - 2009/10/22

N2 - Background: Colorectal cancer (CRC) is one of the leading causes of malignant death worldwide. Because young age of onset is often considered a poor prognostic factor for CRC, it is important to identify the poor outcomes of CRC in a younger population and to consider an aggressive approach by implementing early treatment. Our aim was to specifically quantify the fecal cytokeratin 19 (CK19) transcript from CRC patients and investigate its correlation with clinical stage, tumor malignancy, and age. Methods: The quantitation of fecal CK19 transcript was determined by a quantitative real-time reverse transcription polymerase chain in 129 CRC patients (45 younger than 60 years at diagnosis) and 85 healthy controls. The levels of CK19 protein were examined both in colonic cell lines and tissues. Results: The analysis of 45 younger CRC patients (age ≤ 60 years) revealed that patients at the M1 stage had significantly higher expression levels of fecal CK19 mRNA when compared with healthy controls (p <0.001) and patients at the M0 stage (p = 0.004). Additionally, the degree of consistency between the mean level of fecal CK19 mRNA and the distant metastatic rate in each age interval was up to 89% (p = 0.042). Conclusion: These results indicate that high levels of fecal CK19 mRNA represent a potential marker for colorectal malignancy and for aggressive treatment of younger CRC patients.

AB - Background: Colorectal cancer (CRC) is one of the leading causes of malignant death worldwide. Because young age of onset is often considered a poor prognostic factor for CRC, it is important to identify the poor outcomes of CRC in a younger population and to consider an aggressive approach by implementing early treatment. Our aim was to specifically quantify the fecal cytokeratin 19 (CK19) transcript from CRC patients and investigate its correlation with clinical stage, tumor malignancy, and age. Methods: The quantitation of fecal CK19 transcript was determined by a quantitative real-time reverse transcription polymerase chain in 129 CRC patients (45 younger than 60 years at diagnosis) and 85 healthy controls. The levels of CK19 protein were examined both in colonic cell lines and tissues. Results: The analysis of 45 younger CRC patients (age ≤ 60 years) revealed that patients at the M1 stage had significantly higher expression levels of fecal CK19 mRNA when compared with healthy controls (p <0.001) and patients at the M0 stage (p = 0.004). Additionally, the degree of consistency between the mean level of fecal CK19 mRNA and the distant metastatic rate in each age interval was up to 89% (p = 0.042). Conclusion: These results indicate that high levels of fecal CK19 mRNA represent a potential marker for colorectal malignancy and for aggressive treatment of younger CRC patients.

UR - http://www.scopus.com/inward/record.url?scp=70749139572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70749139572&partnerID=8YFLogxK

U2 - 10.1186/1471-2407-9-376

DO - 10.1186/1471-2407-9-376

M3 - Article

C2 - 19849844

AN - SCOPUS:70749139572

VL - 9

SP - 376

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

M1 - 1471

ER -